184 related articles for article (PubMed ID: 8776705)
1. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study.
Hempel L; Kremens B; Weirich A; Graf N; Zintl F; Ludwig R
Klin Padiatr; 1996; 208(4):186-9. PubMed ID: 8776705
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
[TBL] [Abstract][Full Text] [Related]
3. Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Illhardt T; Ebinger M; Schwarze CP; Feuchtinger T; Furtwängler R; Schlegel PG; Klingebiel T; Greil J; Beck JF; Handgretinger R; Lang P
Klin Padiatr; 2014 Nov; 226(6-7):351-6. PubMed ID: 25431868
[TBL] [Abstract][Full Text] [Related]
4. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M
J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.
Brown E; Hebra A; Jenrette J; Hudspeth M
J Pediatr Hematol Oncol; 2010 Aug; 32(6):e241-3. PubMed ID: 20628317
[TBL] [Abstract][Full Text] [Related]
8. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
Pein F; Michon J; Valteau-Couanet D; Quintana E; Frappaz D; Vannier JP; Philip T; Bergeron C; Baranzelli MC; Thyss A; Stephan JL; Boutard P; Gentet JC; Zucker JM; Tournade MF; Hartmann O
J Clin Oncol; 1998 Oct; 16(10):3295-301. PubMed ID: 9779704
[TBL] [Abstract][Full Text] [Related]
9. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis.
Presson A; Moore TB; Kempert P
J Pediatr Hematol Oncol; 2010 Aug; 32(6):454-61. PubMed ID: 20505538
[TBL] [Abstract][Full Text] [Related]
11. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.
Reinhard H; Schmidt A; Furtwängler R; Leuschner I; Rübe C; Von Schweinitz D; Zoubek A; Niggli F; Graf N
Oncol Rep; 2008 Aug; 20(2):463-7. PubMed ID: 18636212
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
Grodman H; Wolfe L; Kretschmar C
Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
[TBL] [Abstract][Full Text] [Related]
14. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
15. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
16. Melphalan combined with a carboplatin dose based on glomerular filtration rate followed by autologous stem cell rescue for children with solid tumours.
Shaw PJ; Pinkerton CR; Yaniv I
Bone Marrow Transplant; 1996 Dec; 18(6):1043-7. PubMed ID: 8971371
[TBL] [Abstract][Full Text] [Related]
17. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
18. Salvage treatment of relapsing Wilms' tumour by autologous bone marrow transplantation.
Kullendorff CM; Békássy AN
Eur J Pediatr Surg; 1997 Jun; 7(3):177-9. PubMed ID: 9241510
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
